{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:01:07Z","timestamp":1793941267619,"version":"4.8.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T00:00:00Z","timestamp":1545177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Korea Health Technology Research and Development"},{"name":"Ministry of Health &Welfare, Republic of Korea"},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Tau and amyloid \u03b2 (A\u03b2), 2 key pathogenic proteins in Alzheimer\u2019s disease (AD), reportedly spread throughout the brain as the disease progresses. Models of how these pathogenic proteins spread from affected to unaffected areas had been proposed based on the observation that these proteins could transmit to other regions either through neural fibers (transneuronal spread model) or through extracellular space (local spread model). In this study, we modeled the spread of tau and A\u03b2 using a graph theoretical approach based on resting-state functional magnetic resonance imaging. We tested whether these models predict the distribution of tau and A\u03b2 in the brains of AD spectrum patients. To assess the models\u2019 performance, we calculated spatial correlation between the model-predicted map and the actual map from tau and amyloid positron emission tomography. The transneuronal spread model predicted the distribution of tau and A\u03b2 deposition with significantly higher accuracy than the local spread model. Compared with tau, the local spread model also predicted a comparable portion of A\u03b2 deposition. These findings provide evidence of transneuronal spread of AD pathogenic proteins in a large-scale brain network and furthermore suggest different contributions of spread models for tau and A\u03b2 in AD.<\/jats:p>","DOI":"10.1093\/cercor\/bhy311","type":"journal-article","created":{"date-parts":[[2018,11,17]],"date-time":"2018-11-17T02:06:08Z","timestamp":1542420368000},"page":"4291-4302","source":"Crossref","is-referenced-by-count":30,"title":["Comparison of Amyloid \u03b2 and Tau Spread Models in Alzheimer\u2019s Disease"],"prefix":"10.1093","volume":"29","author":[{"given":"Hang-Rai","family":"Kim","sequence":"first","affiliation":[{"name":"Graduate School of Medical Science & Engineering, KAIST, Daejeon, Republic of Korea"},{"name":"KAIST Institute for Health Science and Technology, KAIST, Daejeon, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Lee","sequence":"additional","affiliation":[{"name":"KAIST Institute for Health Science and Technology, KAIST, Daejeon, Republic of Korea"},{"name":"Department of Bio and Brain Engineering, KAIST, Daejeon, 34141 Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Won","family":"Seo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3243-0529","authenticated-orcid":false,"given":"Jee Hoon","family":"Roh","sequence":"additional","affiliation":[{"name":"Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minyoung","family":"Oh","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungsu S","family":"Oh","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Jun","family":"Oh","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Seung","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Jeong","sequence":"additional","affiliation":[{"name":"Graduate School of Medical Science & Engineering, KAIST, Daejeon, Republic of Korea"},{"name":"KAIST Institute for Health Science and Technology, KAIST, Daejeon, Republic of Korea"},{"name":"Department of Bio and Brain Engineering, KAIST, Daejeon, 34141 Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,12,19]]},"reference":[{"key":"2021031603201638400_bhy311C44","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S1474-4422(11)70077-1","article-title":"Cerebral amyloid-\u03b2 PET with florbetaben (18 F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study","volume":"10","author":"Barthel","year":"2011","journal-title":"Lancet Neurol"},{"key":"2021031603201638400_bhy311C1","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1212\/01.wnl.0000219668.47116.e6","article-title":"Neuropathology of older persons without cognitive impairment from two community-based studies","volume":"66","author":"Bennett","year":"2006","journal-title":"Neurology"},{"key":"2021031603201638400_bhy311C2","doi-asserted-by":"crossref","first-page":"996","DOI":"10.2967\/jnumed.116.182980","article-title":"In vivo comparison of tau radioligands 18F-THK-5351 and 18F-THK-5317","volume":"58","author":"Betthauser","year":"2017","journal-title":"J Nucl Med"},{"key":"2021031603201638400_bhy311C3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1750-3639.1991.tb00661.x","article-title":"Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections","volume":"1","author":"Braak","year":"1991","journal-title":"Brain Pathol"},{"key":"2021031603201638400_bhy311C4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"2021031603201638400_bhy311C5","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","article-title":"Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years","volume":"70","author":"Braak","year":"2011","journal-title":"J Neuropathol Exp Neurol"},{"key":"2021031603201638400_bhy311C6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrn3887","article-title":"Spreading of pathology in neurodegenerative diseases: a focus on human studies","volume":"16","author":"Brettschneider","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"2021031603201638400_bhy311C7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ana.24711","article-title":"In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum","volume":"80","author":"Cho","year":"2016","journal-title":"Ann Neurol"},{"key":"2021031603201638400_bhy311C8","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","article-title":"Primary age-related tauopathy (PART): a common pathology associated with human aging","volume":"128","author":"Crary","year":"2014","journal-title":"Acta Neuropathol"},{"key":"2021031603201638400_bhy311C9","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00005072-199904000-00008","article-title":"Alzheimer neuropathologic alterations in aged cognitively normal subjects","volume":"58","author":"Davis","year":"1999","journal-title":"J Neuropathol Exp Neurol"},{"key":"2021031603201638400_bhy311C10","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.neuron.2011.11.033","article-title":"Propagation of tau pathology in a model of early Alzheimer\u2019s disease","volume":"73","author":"de Calignon","year":"2012","journal-title":"Neuron"},{"key":"2021031603201638400_bhy311C11","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/brain\/aww230","article-title":"Like prions: the propagation of aggregated tau and \u03b1-synuclein in neurodegeneration","volume":"140","author":"Goedert","year":"2017","journal-title":"Brain"},{"key":"2021031603201638400_bhy311C12","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.neuroimage.2016.12.077","article-title":"PETPVE12: an SPM toolbox for partial volume effects correction in brain PET\u2013application to amyloid imaging with AV45-PET","volume":"147","author":"Gonzalez-Escamilla","year":"2017","journal-title":"Neuroimage"},{"key":"2021031603201638400_bhy311C13","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s11307-017-1143-1","article-title":"MAO-B inhibitors do not block in vivo flortaucipir ([18 F]-AV-1451) binding","volume":"20","author":"Hansen","year":"2018","journal-title":"Mol Imaging Biol"},{"key":"2021031603201638400_bhy311C14","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2967\/jnumed.117.197426","article-title":"Correlations of 18F-THK5351 PET with postmortem burden of tau and astrogliosis in Alzheimer disease","volume":"59","author":"Harada","year":"2018","journal-title":"J Nucl Med"},{"key":"2021031603201638400_bhy311C15","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2967\/jnumed.115.164848","article-title":"18F-THK5351: a novel PET radiotracer for imaging neurofibrillary pathology in Alzheimer disease","volume":"57","author":"Harada","year":"2016","journal-title":"J Nucl Med"},{"key":"2021031603201638400_bhy311C16","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00401-015-1407-2","article-title":"PART, a distinct tauopathy, different from classical sporadic Alzheimer disease","volume":"129","author":"Jellinger","year":"2015","journal-title":"Acta Neuropathol"},{"key":"2021031603201638400_bhy311C17","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neuroimage.2009.01.057","article-title":"Reducing between scanner differences in multi-center PET studies","volume":"46","author":"Joshi","year":"2009","journal-title":"Neuroimage"},{"key":"2021031603201638400_bhy311C18","doi-asserted-by":"crossref","first-page":"e31302","DOI":"10.1371\/journal.pone.0031302","article-title":"Trans-synaptic spread of tau pathology in vivo","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS One"},{"key":"2021031603201638400_bhy311C19","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0197-4580(97)00064-X","article-title":"Neuropathological criteria for the diagnosis of Alzheimer\u2019s disease","volume":"18","author":"Markesbery","year":"1997","journal-title":"Neurobiol Aging"},{"key":"2021031603201638400_bhy311C45","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"2021031603201638400_bhy311C20","doi-asserted-by":"crossref","first-page":"e536","DOI":"10.1371\/journal.pone.0000536","article-title":"Mitochondrial oxidative stress causes hyperphosphorylation of tau","volume":"2","author":"Melov","year":"2007","journal-title":"PLoS One"},{"key":"2021031603201638400_bhy311C21","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.neuroimage.2008.09.036","article-title":"The impact of global signal regression on resting state correlations: are anti-correlated networks introduced?","volume":"44","author":"Murphy","year":"2009","journal-title":"Neuroimage"},{"key":"2021031603201638400_bhy311C22","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1093\/brain\/awx279","article-title":"Distinct influence of specific versus global connectivity on the different Alzheimer\u2019s disease biomarkers","volume":"140","author":"Mutlu","year":"2017","journal-title":"Brain"},{"key":"2021031603201638400_bhy311C23","doi-asserted-by":"crossref","first-page":"8767","DOI":"10.1523\/JNEUROSCI.0615-12.2012","article-title":"Spreading of neurodegenerative pathology via neuron-to-neuron transmission of \u03b2-amyloid","volume":"32","author":"Nath","year":"2012","journal-title":"J Neurosci"},{"key":"2021031603201638400_bhy311C24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13195-017-0253-y","article-title":"Monoamine oxidase B inhibitor, selegiline, reduces 18 F-THK5351 uptake in the human brain","volume":"9","author":"Ng","year":"2017","journal-title":"Alzheimers Res Ther"},{"key":"2021031603201638400_bhy311C25","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild cognitive impairment: clinical characterization and outcome","volume":"56","author":"Petersen","year":"1999","journal-title":"Arch Neurol"},{"key":"2021031603201638400_bhy311C26","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.neuron.2011.09.006","article-title":"Functional network organization of the human brain","volume":"72","author":"Power","year":"2011","journal-title":"Neuron"},{"key":"2021031603201638400_bhy311C27","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.neuron.2011.12.040","article-title":"A network diffusion model of disease progression in dementia","volume":"73","author":"Raj","year":"2012","journal-title":"Neuron"},{"key":"2021031603201638400_bhy311C28","doi-asserted-by":"crossref","first-page":"11172","DOI":"10.1073\/pnas.0603838103","article-title":"Alzheimer\u2019s disease \u03b2-amyloid peptides are released in association with exosomes","volume":"103","author":"Rajendran","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021031603201638400_bhy311C29","first-page":"904","article-title":"Correction for partial volume effects in PET: principle and validation","volume":"39","author":"Rousset","year":"1998","journal-title":"J Nucl Med"},{"key":"2021031603201638400_bhy311C30","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.neuroimage.2009.10.003","article-title":"Complex network measures of brain connectivity: uses and interpretations","volume":"52","author":"Rubinov","year":"2010","journal-title":"Neuroimage"},{"key":"2021031603201638400_bhy311C31","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","article-title":"PET imaging of tau deposition in the aging human brain","volume":"89","author":"Sch\u00f6ll","year":"2016","journal-title":"Neuron"},{"key":"2021031603201638400_bhy311C32","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuron.2009.03.024","article-title":"Neurodegenerative diseases target large-scale human brain networks","volume":"62","author":"Seeley","year":"2009","journal-title":"Neuron"},{"key":"2021031603201638400_bhy311C33","doi-asserted-by":"crossref","first-page":"900","DOI":"10.2967\/jnumed.115.161927","article-title":"Impact of training method on the robustness of the visual assessment of 18F-Florbetaben PET scans: results from a phase-3 study","volume":"57","author":"Seibyl","year":"2016","journal-title":"J Nucl Med"},{"key":"2021031603201638400_bhy311C34","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-018-0206-4","article-title":"Neurogenetic contributions to amyloid beta and tau spreading in the human cortex","author":"Sepulcre","year":"2018","journal-title":"Nat Med"},{"key":"2021031603201638400_bhy311C35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000334915","article-title":"Tau overexpression results in its secretion via membrane vesicles","volume":"10","author":"Sim\u00f3n","year":"2012","journal-title":"Neurodegener Dis"},{"key":"2021031603201638400_bhy311C36","first-page":"35","article-title":"Regional tau deposition and subregion atrophy of medial temporal structures in early Alzheimer\u2019s disease: a combined positron emission tomography\/magnetic resonance imaging study","volume":"9","author":"Sone","year":"2017","journal-title":"Alzheimers Dement"},{"key":"2021031603201638400_bhy311C37","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/ana.24029","article-title":"\u03b2-Amyloid is transmitted via neuronal connections along axonal membranes","volume":"75","author":"Song","year":"2014","journal-title":"Ann Neurol"},{"key":"2021031603201638400_bhy311C38","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of A\u03b2-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"key":"2021031603201638400_bhy311C39","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/nimg.2001.0978","article-title":"Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain","volume":"15","author":"Tzourio-Mazoyer","year":"2002","journal-title":"Neuroimage"},{"key":"2021031603201638400_bhy311C40","doi-asserted-by":"crossref","first-page":"17763","DOI":"10.1073\/pnas.1010461107","article-title":"Spatial correlation between brain aerobic glycolysis and amyloid-\u03b2 (A\u03b2) deposition","volume":"107","author":"Vlassenko","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021031603201638400_bhy311C41","doi-asserted-by":"crossref","first-page":"822","DOI":"10.2967\/jnumed.117.194720","article-title":"Spatiotemporal distribution of \u03b2-amyloid in Alzheimer disease is the result of heterogeneous regional carrying capacities","volume":"59","author":"Whittington","year":"2018","journal-title":"J Nucl Med"},{"key":"2021031603201638400_bhy311C42","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/nn.4328","article-title":"Neuronal activity enhances tau propagation and tau pathology in vivo","volume":"19","author":"Wu","year":"2016","journal-title":"Nat Neurosci"},{"key":"2021031603201638400_bhy311C43","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.neuron.2012.03.004","article-title":"Predicting regional neurodegeneration from the healthy brain functional connectome","volume":"73","author":"Zhou","year":"2012","journal-title":"Neuron"}],"container-title":["Cerebral Cortex"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cercor\/article-pdf\/29\/10\/4291\/36604778\/bhy311.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cercor\/article-pdf\/29\/10\/4291\/36604778\/bhy311.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T03:21:38Z","timestamp":1615864898000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cercor\/article\/29\/10\/4291\/5253203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,19]]},"references-count":45,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,12,19]]},"published-print":{"date-parts":[[2019,9,13]]}},"URL":"https:\/\/doi.org\/10.1093\/cercor\/bhy311","relation":{},"ISSN":["1047-3211","1460-2199"],"issn-type":[{"value":"1047-3211","type":"print"},{"value":"1460-2199","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,10]]},"published":{"date-parts":[[2018,12,19]]}}}